The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Swine Influenza Vaccines Market Research Report 2025
Synopsis
Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
The global Swine Influenza Vaccines market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 167.4 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Swine Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Influenza Vaccines.
Report Scope
The Swine Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Commodity Pig
Breeding Pig
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
The global Swine Influenza Vaccines market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 167.4 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Swine Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Influenza Vaccines.
Report Scope
The Swine Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Commodity Pig
Breeding Pig
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Swine Influenza Vaccines Market Overview
1.1 Product Overview and Scope of Swine Influenza Vaccines
1.2 Swine Influenza Vaccines Segment by Type
1.2.1 Global Swine Influenza Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Swine Influenza Vaccines Segment by Application
1.3.1 Global Swine Influenza Vaccines Market Value by Application: (2024-2030)
1.3.2 Commodity Pig
1.3.3 Breeding Pig
1.4 Global Swine Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Influenza Vaccines Revenue 2019-2030
1.4.2 Global Swine Influenza Vaccines Sales 2019-2030
1.4.3 Global Swine Influenza Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Swine Influenza Vaccines Market Competition by Manufacturers
2.1 Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Swine Influenza Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Swine Influenza Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Swine Influenza Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Influenza Vaccines, Product Type & Application
2.7 Swine Influenza Vaccines Market Competitive Situation and Trends
2.7.1 Swine Influenza Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Influenza Vaccines Players Market Share by Revenue
2.7.3 Global Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Influenza Vaccines Retrospective Market Scenario by Region
3.1 Global Swine Influenza Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Swine Influenza Vaccines Global Swine Influenza Vaccines Sales by Region: 2019-2030
3.2.1 Global Swine Influenza Vaccines Sales by Region: 2019-2024
3.2.2 Global Swine Influenza Vaccines Sales by Region: 2025-2030
3.3 Global Swine Influenza Vaccines Global Swine Influenza Vaccines Revenue by Region: 2019-2030
3.3.1 Global Swine Influenza Vaccines Revenue by Region: 2019-2024
3.3.2 Global Swine Influenza Vaccines Revenue by Region: 2025-2030
3.4 North America Swine Influenza Vaccines Market Facts & Figures by Country
3.4.1 North America Swine Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Swine Influenza Vaccines Sales by Country (2019-2030)
3.4.3 North America Swine Influenza Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Swine Influenza Vaccines Market Facts & Figures by Country
3.5.1 Europe Swine Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Swine Influenza Vaccines Sales by Country (2019-2030)
3.5.3 Europe Swine Influenza Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Influenza Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Swine Influenza Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Swine Influenza Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Swine Influenza Vaccines Market Facts & Figures by Country
3.7.1 Latin America Swine Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Swine Influenza Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Swine Influenza Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Influenza Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Swine Influenza Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Swine Influenza Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Influenza Vaccines Sales by Type (2019-2030)
4.1.1 Global Swine Influenza Vaccines Sales by Type (2019-2024)
4.1.2 Global Swine Influenza Vaccines Sales by Type (2025-2030)
4.1.3 Global Swine Influenza Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Swine Influenza Vaccines Revenue by Type (2019-2030)
4.2.1 Global Swine Influenza Vaccines Revenue by Type (2019-2024)
4.2.2 Global Swine Influenza Vaccines Revenue by Type (2025-2030)
4.2.3 Global Swine Influenza Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Swine Influenza Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Swine Influenza Vaccines Sales by Application (2019-2030)
5.1.1 Global Swine Influenza Vaccines Sales by Application (2019-2024)
5.1.2 Global Swine Influenza Vaccines Sales by Application (2025-2030)
5.1.3 Global Swine Influenza Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Swine Influenza Vaccines Revenue by Application (2019-2030)
5.2.1 Global Swine Influenza Vaccines Revenue by Application (2019-2024)
5.2.2 Global Swine Influenza Vaccines Revenue by Application (2025-2030)
5.2.3 Global Swine Influenza Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Swine Influenza Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chengdu TECBOND
6.1.1 Chengdu TECBOND Corporation Information
6.1.2 Chengdu TECBOND Description and Business Overview
6.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chengdu TECBOND Swine Influenza Vaccines Product Portfolio
6.1.5 Chengdu TECBOND Recent Developments/Updates
6.2 Green Cross Veterinary
6.2.1 Green Cross Veterinary Corporation Information
6.2.2 Green Cross Veterinary Description and Business Overview
6.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Green Cross Veterinary Swine Influenza Vaccines Product Portfolio
6.2.5 Green Cross Veterinary Recent Developments/Updates
6.3 Hipra
6.3.1 Hipra Corporation Information
6.3.2 Hipra Description and Business Overview
6.3.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hipra Swine Influenza Vaccines Product Portfolio
6.3.5 Hipra Recent Developments/Updates
6.4 MSD Animal Health (Merck)
6.4.1 MSD Animal Health (Merck) Corporation Information
6.4.2 MSD Animal Health (Merck) Description and Business Overview
6.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio
6.4.5 MSD Animal Health (Merck) Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Corporation Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zoetis Swine Influenza Vaccines Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 CAHIC
6.6.1 CAHIC Corporation Information
6.6.2 CAHIC Description and Business Overview
6.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CAHIC Swine Influenza Vaccines Product Portfolio
6.6.5 CAHIC Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Ceva
6.8.1 Ceva Corporation Information
6.8.2 Ceva Description and Business Overview
6.8.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ceva Swine Influenza Vaccines Product Portfolio
6.8.5 Ceva Recent Developments/Updates
6.9 Ringpu Biology
6.9.1 Ringpu Biology Corporation Information
6.9.2 Ringpu Biology Description and Business Overview
6.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ringpu Biology Swine Influenza Vaccines Product Portfolio
6.9.5 Ringpu Biology Recent Developments/Updates
6.10 DHN
6.10.1 DHN Corporation Information
6.10.2 DHN Description and Business Overview
6.10.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 DHN Swine Influenza Vaccines Product Portfolio
6.10.5 DHN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Influenza Vaccines Industry Chain Analysis
7.2 Swine Influenza Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Influenza Vaccines Production Mode & Process
7.4 Swine Influenza Vaccines Sales and Marketing
7.4.1 Swine Influenza Vaccines Sales Channels
7.4.2 Swine Influenza Vaccines Distributors
7.5 Swine Influenza Vaccines Customers
8 Swine Influenza Vaccines Market Dynamics
8.1 Swine Influenza Vaccines Industry Trends
8.2 Swine Influenza Vaccines Market Drivers
8.3 Swine Influenza Vaccines Market Challenges
8.4 Swine Influenza Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
